Posted on December 17, 202512/17/25
The Enablement Helix: An Evolving Framework for Market Success in Oncology
Posted on November 30, 202511/30/25
The Oncologist’s Next Ally: Why Cancer Is Forging the Future of Clinical AI
Posted on October 31, 202510/31/25
AI in Oncology: Acceleration, Accessibility, and Accuracy
Posted on October 30, 202510/30/25
AI at ESMO 2025: Navigating the New Frontier of Opportunity and Obstacles in Oncology
Posted on August 21, 20258/21/25
Redefining CAR-T Access: Strategic Implications of the FDA’s REMS Decision
Posted on July 21, 20257/21/25
Empowering Scientific Dialogue: Key Takeaways from the FDA’s SIUU Guidance
Posted on May 29, 20255/29/25
Navigating the Final FDA SIUU Guidance: Strategic Considerations for Scientific Exchange at ASCO and Other Congresses
Posted on April 3, 20254/3/25
Beyond Clinical Trials: Real-World Evidence Illuminates the Value of First-Line CDK4/6i in Metastatic Breast Cancer
Posted on March 12, 20253/12/25